These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3987619)
41. Differential effects of estradiol and 16 alpha-hydroxyestrone on pituitary and preoptic estrogen receptor regulation. Lustig RH; Mobbs CV; Bradlow HL; McEwen BS; Pfaff DW Endocrinology; 1989 Nov; 125(5):2701-9. PubMed ID: 2792004 [TBL] [Abstract][Full Text] [Related]
42. Induction of progesterone receptor by androgens in the mouse uterus. Ho SM; Levin V Mol Cell Endocrinol; 1986 Jul; 46(2):103-8. PubMed ID: 3721057 [TBL] [Abstract][Full Text] [Related]
43. Androgen-uterine interaction: nuclear translocation of the estrogen receptor and induction of the synthesis of the uterine-induced protein (IP) by high concentrations of androgens in vitro but not in vivo. Schmidt WN; Sadler MA; Katzenellenbogen BS Endocrinology; 1976 Mar; 98(3):702-16. PubMed ID: 177269 [TBL] [Abstract][Full Text] [Related]
44. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
45. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo. Nardulli AM; Katzenellenbogen BS Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Kuiper GG; Carlsson B; Grandien K; Enmark E; Häggblad J; Nilsson S; Gustafsson JA Endocrinology; 1997 Mar; 138(3):863-70. PubMed ID: 9048584 [TBL] [Abstract][Full Text] [Related]
47. Expression of steroid receptors in intact rat uterus, mammary gland, and liver treated with selective estrogen receptor modulators and conjugated equine estrogens. Bayram M; Bayram O; Dursun A; Isik I; Dilekoz E; Ozkan S Adv Ther; 2005; 22(6):587-94. PubMed ID: 16510375 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018. Jordan VC; Gosden B Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937 [TBL] [Abstract][Full Text] [Related]
49. Estrogen and progesterone receptors in the fetal and newborn vagina of guinea pig: biological, morphological, and ultrastructural responses to tamoxifen and estradiol. Nguyen BL; Giambiagi N; Mayrand C; Lecerf F; Pasqualini JR Endocrinology; 1986 Sep; 119(3):978-88. PubMed ID: 3732174 [TBL] [Abstract][Full Text] [Related]
50. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells. Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of rat uterine gland genesis by tamoxifen. Branham WS; Sheehan DM; Zehr DR; Medlock KL; Nelson CJ; Ridlon E Endocrinology; 1985 Nov; 117(5):2238-48. PubMed ID: 4042985 [TBL] [Abstract][Full Text] [Related]
53. Strain differences in tamoxifen sensitivity of Sprague-Dawley and Fischer 344 rats. Bailey JA; Nephew KP Anticancer Drugs; 2002 Oct; 13(9):939-47. PubMed ID: 12394257 [TBL] [Abstract][Full Text] [Related]
54. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352 [TBL] [Abstract][Full Text] [Related]
55. The interaction of estrogen- and antiestrogen-receptor complexes with polynucleotides. Murphy LC; Sutherland RL Endocrinology; 1983 Feb; 112(2):707-14. PubMed ID: 6848368 [TBL] [Abstract][Full Text] [Related]
56. Effects on mouse uterus of three antitumoral drugs acting upon estrogen and progesterone receptors directly and through other transduction pathways. Actis AM; Dorfman VB; Caruso SP; Levin E Biochem Pharmacol; 1998 Feb; 55(3):273-8. PubMed ID: 9484792 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, structure and biological properties of Z-17alpha-(2-iodovinyl)-11beta-chloromethyl estradiol-17beta (Z-CMIV), a high affinity ligand for the characterization of estrogen receptor-positive tumors. Quivy J; Leclercq G; Deblaton M; Henrot P; Velings N; Norberg B; Evrard G; Zeicher M J Steroid Biochem Mol Biol; 1996 Sep; 59(1):103-17. PubMed ID: 9009243 [TBL] [Abstract][Full Text] [Related]
58. Melatonin-induced increase in cytoplasmic estrogen receptor activity in hamster uteri. Danforth DN; Tamarkin L; Do R; Lippman ME Endocrinology; 1983 Jul; 113(1):81-5. PubMed ID: 6861717 [TBL] [Abstract][Full Text] [Related]
59. The estrogenic and antiestrogenic properties of tamoxifen in GH4C1 pituitary tumor cells are gene specific. Shull JD; Beams FE; Baldwin TM; Gilchrist CA; Hrbek MJ Mol Endocrinol; 1992 Apr; 6(4):529-35. PubMed ID: 1584221 [TBL] [Abstract][Full Text] [Related]